Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Bernstein’s Bold Call: Coinbase Shares Poised for Major Rally

Dieter Jaworski by Dieter Jaworski
December 3, 2025
in Analysis, Bitcoin, Blockchain, Crypto Stocks, Insider Trading
0
Coinbase Stock
0
SHARES
13
VIEWS
Share on FacebookShare on Twitter

Despite recent weakness across Bitcoin and broader cryptocurrency markets, Coinbase is capturing significant analyst attention. Research firm Bernstein has reaffirmed an exceptionally bullish stance, projecting the stock could surge to $510. This represents a potential near-doubling from its current trading level around $263. The optimistic outlook emerges alongside notable but conflicting trading activity: prominent investor Cathie Wood is adding to her position, while a company insider has been selling.

From Crypto Exchange to Comprehensive Financial Platform

Bernstein analyst Gautam Chhugani maintains his “Outperform” rating and $510 price target, implying upside of approximately 94%. The core thesis is that Coinbase is successfully transforming into a broad-based financial ecosystem, reducing its historical reliance on volatile spot trading. The analyst highlights the company’s substantial and growing revenue streams from custody services, stablecoins, and its proprietary Layer-2 blockchain, Base.

According to Bernstein, current market fragility is not comparable to past crypto cycle crashes. The firm points to stronger underlying fundamentals and continued institutional adoption as key differentiators. Coinbase’s third-quarter revenue of $1.87 billion, which exceeded expectations, is cited as clear evidence of a resilient and effective business model.

Divergent Signals from Major Investors

Recent trading patterns reveal a split in sentiment. On December 2, Cathie Wood’s ARK Invest purchased an additional 28,315 shares, demonstrating confidence following the stock’s pullback from yearly highs. Conversely, Coinbase’s Chief Legal Officer, Paul Grewal, sold close to 13,000 shares in late November at prices near $260. While such insider sales are often pre-scheduled, the divergence between ARK’s buying and the insider’s disposal presents a nuanced picture.

Should investors sell immediately? Or is it worth buying Coinbase?

Concurrently, Coinbase continues its product rollout. The recent introduction of “Instant Unstaking” for U.S. customers allows users to quickly liquidate staked coins for a 1% fee. This feature addresses a common user concern and is expected to stimulate greater activity, particularly within the retail segment.

Key Technical and Catalytic Levels Ahead

Having corrected significantly from its 52-week high near $420, the stock faces a divided analyst community. Bernstein’s $510 target contrasts with Barclays’ more conservative “Hold” rating and $357 price objective. From a technical perspective, reclaiming the $270 level is viewed as a necessary step to alleviate near-term downward pressure.

Market participants are looking ahead to a product event scheduled for December 17. Bernstein anticipates announcements regarding tokenized equities and prediction markets, which could bring the vision of a comprehensive “everything marketplace” into sharper focus.

Ad

Coinbase Stock: Buy or Sell?! New Coinbase Analysis from February 7 delivers the answer:

The latest Coinbase figures speak for themselves: Urgent action needed for Coinbase investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Coinbase: Buy or sell? Read more here...

Tags: Coinbase
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

Avanos Medical Stock
Analysis

Avanos Medical’s Strategic Pivot: A Focus on High-Margin Growth

February 7, 2026
Guaranty Bancshares Stock
Analysis

Guaranty Bancshares Sees Growth Accelerate Following Texas Expansion

February 7, 2026
Yirendai Stock
AI & Quantum Computing

Yirendai Charts a New Course with Tech-Driven Strategy

February 7, 2026
Next Post
Take-Two Stock

A Bullish Case Emerges for Take-Two Interactive

Nippon SteelADR Stock

Nippon Steel Doubles Down on US Market with Major New Investment

Oracle Stock

Oracle's Critical Juncture: A Pivotal Earnings Report Looms

Recommended

C3.ai Stock

Is C3.ai Stock Poised for a Rebound?

2 months ago
MMM stock news

Clarification on Hyperlink and Promotional Fees

2 years ago

XOMA Corporation Expands Portfolio with Acquisition of DSUVIA

2 years ago
Microsoft Stock

A Bold Bet: Peter Thiel’s Hedge Fund Doubles Down on Microsoft

1 month ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

ServiceNow Shares Face Market Skepticism Despite Record Performance

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

A New Chapter for First Busey as CrossFirst Merger Finalizes

Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

Myers Industries Set to Report Full-Year and Q4 2025 Results

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

Trending

Avanos Medical Stock
Analysis

Avanos Medical’s Strategic Pivot: A Focus on High-Margin Growth

by SiterGedge
February 7, 2026
0

Avanos Medical is navigating a critical strategic transformation. The medical device firm is streamlining its operations to...

Guaranty Bancshares Stock

Guaranty Bancshares Sees Growth Accelerate Following Texas Expansion

February 7, 2026
Yirendai Stock

Yirendai Charts a New Course with Tech-Driven Strategy

February 7, 2026
ServiceNow Stock

ServiceNow Shares Face Market Skepticism Despite Record Performance

February 7, 2026
Orthofix Medical Stock

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Avanos Medical’s Strategic Pivot: A Focus on High-Margin Growth
  • Guaranty Bancshares Sees Growth Accelerate Following Texas Expansion
  • Yirendai Charts a New Course with Tech-Driven Strategy

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com